Prevalence of metabolic syndrome and its relationship with clinically prevalent cardiovascular disease in the veneto region, Northeastern Italy

Metabolic Syndrome and Related Disorders

Volumn 10, Issue 1, 2012, Pages 56-62

  Novelletto, Bruno Franco ^a   Guzzinati, Stefano ^b   Avogaro, Angelo ^c  

^a Società Italiana di Medicina Generale Padova   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY BYPASS GRAFT; DISEASE ASSOCIATION; FEMALE; GROUPS BY AGE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; ITALY; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; STROKE; WAIST CIRCUMFERENCE;

ADULT; AGE FACTORS; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; ITALY; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; WAIST CIRCUMFERENCE;

EID: 84856038423     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2011.0065     Document Type: Article

References (46)

1. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: A summary of the evidence. Diabetes Care 2005;28:1769-1778. (Pubitemid 40923091)
2. Malik S, Wong ND, Franklin SS et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in united states adults. Circulation 2004;110:1245-1250. (Pubitemid 39202340)
3. Church TS, Thompson AM, Katzmarzyk PT et al. Metabolic syndrome and diabetes, alone and in combination, as predictors of cardiovascular disease mortality among men. Diabetes Care 2009;32:1289-1294.
4. Lorenzo C, Williams K, Hunt KJ et al. Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence: The San Antonio Heart Study. Diabetes Care 2006;29:625-630. (Pubitemid 44115364)
5. Lorenzo C, Williams K, Hunt KJ et al. The National Cholesterol Education Program Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 2007; 30:8-13. (Pubitemid 46052493)
6. Butler J, Rodondi N, Zhu Y et al. Metabolic syndrome and the risk of cardiovascular disease in older adults. J Am Coll Cardiol 2006;47:1595-1602.
7. Jeppesen J, Hansen TW, Rasmussen S et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: A population-based study. J Am Coll Cardiol 2007;49:2112-2119. (Pubitemid 46771048)
8. Wilson PW, D'Agostino RB, Parise H et al. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005;112:3066-3072. (Pubitemid 43113437)
9. Ginsberg HN, MacCallum PR. The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus. J Cardiometab Syndr 2009;4:113-119.
10. Sattar N, McConnachie A, Shaper AG et al. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet 2008;371:1927-1935.
11. Haring R, Wallaschofski H, Nauck M et al. Total and cardiovascular disease mortality predicted by metabolic syndrome is inferior relative to its components. Exp Clin Endocrinol Diabetes 2010;118:685-691.
12. Gupta AK, Dahlof B, Sever PS et al. Metabolic syndrome, independent of its components, is a risk factor for stroke and death but not for coronary heart disease among hypertensive patients in the ASCOT-BPLA. Diabetes Care 2010;33:1647-1651.
13. Reaven GM. The metabolic syndrome: Is this diagnosis necessary? Am J Clin Nutr 2006;83:1237-1247. (Pubitemid 44713049)
14. Reaven GM. Insulin resistance, cardiovascular disease, and the metabolic syndrome: How well do the emperor's clothes fit? Diabetes Care 2004;27:1011-1012. (Pubitemid 38420232)
15. Ferrannini E. Is insulin resistance the cause of the metabolic syndrome? Ann Med 2006;38:42-51. (Pubitemid 43177787)
16. Meigs JB, Rutter MK, Sullivan LM et al. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care 2007;30:1219-1225. (Pubitemid 46684651)
17. Meigs JB, Wilson PW, Nathan DM et al. in the San Antonio Heart and Framingham Offspring Studies. Diabetes 2003;52: 2160-2167.
18. Sone H, Tanaka S, Iimuro S et al. Components of metabolic syndrome and their combinations as predictors of cardiovascular disease in Japanese patients with type 2 diabetes. Implications for improved definition. Analysis from Japan Diabetes Complications Study (JDCS). J Atheroscler Thromb 2009;16:380-387.
19. Knuiman MW, Hung J, Divitini ML et al. Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: A prospective cohort study. Eur J Cardiovasc Prev Rehabil 2009;16: 235-241.
20. Kokubo Y, Okamura T, Yoshimasa Y et al. Impact of metabolic syndrome components on the incidence of cardiovascular disease in a general urban Japanese population: The Suita Study. Hypertens Res 2008;31:2027-2035.
21. Azevedo A, Bettencourt P, Almeida PB et al. Increasing number of components of the metabolic syndrome and cardiac structural and functional abnormalities-cross-sectional study of the general population. BMC Cardiovasc Disord 2007;7:17.
22. Nakanishi N, Takatorige T, Fukuda H et al. Components of the metabolic syndrome as predictors of cardiovascular disease and type 2 diabetes in middle-aged Japanese men. Diabetes Res Clin Pract 2004;64:59-70. (Pubitemid 38249458)
23. Klein BE, Klein R, Lee KE. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care 2002;25:1790-1794. (Pubitemid 41071088)
24. Hanefeld M, Koehler C, Gallo S et al. Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: The Diabetes in Germany (DIG) study. Cardiovasc Diabetol 2007;6:13.
25. Nigam A, Bourassa MG, Fortier A et al. The metabolic syndrome and its components and the long-term risk of death in patients with coronary heart disease. Am Heart J 2006;151:514-521. (Pubitemid 43144759)
26. Franco OH, Massaro JM, Civil J et al. Trajectories of entering the metabolic syndrome: The framingham heart study. Circulation 2009;120:1943-1950.
27. Bonora E, Targher G, Formentini G et al. The metabolic syn-dromeisan independent predictorofcardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. Diabet Med 2004;21:52-58. (Pubitemid 38168029)
28. Bonora E, Kiechl S, Willeit J et al. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: Prospective data from the Bruneck study. Diabetes Care 2003;26:1251-1257. (Pubitemid 36929281)
29. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. JAMA 2002;287:356-359. (Pubitemid 34251969)
30. Bonora E, Kiechl S, Willeit J et al. Metabolic syndrome: Epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study. Int J Obes Relat Metab Disord 2003;27:1283-1289. (Pubitemid 37281677)
31. Miccoli R, Bianchi C, Odoguardi L et al. Prevalence of the metabolic syndrome among Italian adults according to ATP III definition. Nutr Metab Cardiovasc Dis 2005;15:250-254. (Pubitemid 41190981)
32. Cicero AF, Nascetti S, Noera G et al. Metabolic syndrome prevalence in Italy. Nutr Metab Cardiovasc Dis 2006;16:e5-e6. (Pubitemid 44404007)
33. Scholze J, Alegria E, Ferri C et al. Epidemiological and economic burden of metabolic syndrome and its consequences in patients with hypertension in Germany, Spain and Italy; a prevalence-based model. BMC Public Health 2010;10:529.
34. Thanopoulou A, Karamanos B, Angelico F et al. Epidemio-logical evidence for the non-random clustering of the components of the metabolic syndrome: Multicentre study of the Mediterranean Group for the Study of Diabetes. Eur J Clin Nutr 2006; 60:1376-1383. (Pubitemid 44857623)
35. Guize L, Pannier B, Thomas F et al. Recent advances in metabolic syndrome and cardiovascular disease. Arch Car-diovasc Dis 2008;101:577-583.
36. Kuk JL, Ardern CI. Age and sex differences in the clustering of metabolic syndrome factors: Association with mortality risk. Diabetes Care 2010;33:2457-2461.
37. Sone H, Mizuno S, Fujii H et al. Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in asian diabetic patients? Analysis from the Japan Diabetes Complications Study. Diabetes Care 2005;28:1463-1471. (Pubitemid 40756714)
38. Wirfält E, Hedblad B, Gullberg B et al. Food patterns and components of the metabolic syndrome in men and women: A cross-sectional study within the Malmö Diet and Cancer Cohort. Am J Epidemiol 2001;154:1150-1159. (Pubitemid 33140639)
39. The DAISG. The prevalence of coronary heart disease in Type 2 diabetic patients in Italy: The DAI study. Diabetic Med 2004;21:738-745.
40. Ilanne-Parikka P, Eriksson JG, Lindström J et al. Prevalence of the metabolic syndrome and its components. Diabetes Care 2004;27:2135-2140.
41. Gerstein HC. Dysglycemia and cardiovascular risk in the general population. Circulation 2009;119:773-775.
42. Writing C, Unwin N, Shaw J et al. Impaired glucose tolerance and impaired fasting glycaemia: The current status on definition and intervention. Diabetic Med 2002;19:708-723. (Pubitemid 35013848)
43. Mottillo S, Filion KB, Genest J et al. The metabolic syndrome and cardiovascular risk: A systematic review and meta-analysis. J Am Coll Cardiol 2010;56:1113-1132.
44. Guzder RN, Gatling W, Mullee MA et al. Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes. Diabetologia 2006;49:49-55. (Pubitemid 43151613)
45. McCarthy J, Meyer J, Moliterno D et al. Evidence for substantial effect modification by gender in a large-scale genetic association study of the metabolic syndrome among coronary heart disease patients. Hum Genet 2003;114:87-98. (Pubitemid 38165539)
46. Kolovou GD, Anagnostopoulou KK, Pavlidis AN et al. Metabolic syndrome and gender differences in postprandial lipaemia. Eur J Cardiovasc Prev Rehabil 2006;13:661-664. (Pubitemid 44162173)